TRML Tourmaline Bio Inc: Multiplikator forward rega marang pendapatan
Tourmaline Bio, Inc. (TRML) achieves cost minimization by delegating tests to external CRO networks. This forward P/S metric chart on GURU.Markets demonstrates a balance of expenses, where the indicator reflects current dynamics. Business scalability relies on the global replicability of antibody formulas, while growing authority in immunology confirms the effectiveness of heart inflammation therapy.
Rincian metrik komprehensif lan analitis Tourmaline (TRML)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Tourmaline Bio, Inc.|TRML - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Tourmaline Bio, Inc.|TRML - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Tourmaline|TRML - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Tourmaline Bio|Rasio cepet tourmalinebio.com
- data bathi bisnis lan rasio investasi:
TRML - Asil keuangan resik|Bathi sing dikarepake Tourmaline Bio, Inc.|TRML - Pangali rega marang bathi|Pangali Forward P/E Tourmaline Corp|TRML - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tourmaline|TRML - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Tourmaline Bio|TRML - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan tourmalinebio.com|TRML - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Tourmaline Bio, Inc.
- rincian pendapatan lan dodolan:
Analisis kabeh metrik perusahaan:Tourmaline Bio TRML
The forward P/S reflects the market value of Tourmaline Bio, Inc. (TRML) relative to its expected future sales volume. This indicator measures the premium the market is willing to pay per unit of projected revenue, accounting for discounted growth prospects. Analyzing the forward price-to-sales ratio allows for an assessment of whether the capitalization is appropriate within the context of the development of several antibody programs. The diversification of clinical trials reduces fundamental risks, stabilizing the dynamics of this metric.
Pesaing Tourmaline Bio, Inc.
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABVX: Multiplikator forward rega marang pendapatan|ADMA Corp - Rasio rega marang pendapatan sing dikarepake|Protagonist Therapeutics (PTGX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep immunovant.com (IMVT)|Multiplikator forward rega marang pendapatan KNSA|Multiplikator Forward P/S Grifols SA|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|CLDX (Celldex Corp) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Aurinia Pharmaceuticals AUPH|BCRX - Multiplikator forward rega marang pendapatan|Vera Therapeutics - Multiplikator Forward P/S|DNTH - Multiplikator Forward P/S|Pharvaris Corp (PHVS) - Rasio rega marang prakiraan pendapatan|ABCL (AbCellera Corp) - Rasio rega marang prakiraan pendapatan|PGEN (Precigen, Inc.) - Multiplikator Forward P/S|pharming.com (PHAR) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Nektar Therapeutics Inc. (NKTR)|Upstream Bio, Inc. - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S ZBIO (Zenas Biopharma, Inc.)|Immunome Bio (IMNM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GOSS: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan KALV (kalvista.com)|SEPN: Multiplikator Forward P/S|PVLA (Pieris Pharma) - Rasio rega marang prakiraan pendapatan|SVRA (Savara Corp) - Multiplikator Forward P/S|Rigel Corp (RIGL) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan AnaptysBio, Inc. (ANAB)|ATXS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|enGene - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan RAPT|Aerovate - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Aclaris Therapeutics, Inc ACRS|Kyverna Therapeutics (KYTX) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan TLSA|CABA (Cabaletta Bio) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Ventyx Biosciences Inc. (VTYX)|Multiplikator forward rega marang pendapatan THTX (Theratechnologies Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Avalo Therapeutics Inc|Eledon Pharmaceuticals - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake AGEN (agenusbio.com)|CLYM - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan ZURA (Zura Bio Ltd)|aTyr (ATYR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Adagene Inc.|Rasio rega marang prakiraan pendapatan ImageneBio|Rasio rega marang prakiraan pendapatan STTK|Rasio rega marang prakiraan pendapatan Equillium, Inc. (EQ)|CNTB: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S IMUX (Immunic)|Rega forward marang dodolan ATRA|InflaRx GmbH - Multiplikator Forward P/S|XFOR - Multiplikator Forward P/S|adicetbio.com (ACET) - Rasio rega marang prakiraan pendapatan|Celularity - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan INmune Bio Corp|Multiplikator forward rega marang pendapatan Barinthus Biotherapeutics Corp (BRNS)|Multiplikator Forward P/S KZR|Multiplikator Forward P/S sabbiotherapeutics.com (SABS)|Akari Therapeutics Plc - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ENLV|Q32 Bio Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan ibioinc.com|Rasio rega marang prakiraan pendapatan Carisma Therapeutics Inc|Multiplikator forward rega marang pendapatan XTL Biopharmaceuticals Ltd (XTLB)|Multiplikator forward rega marang pendapatan BOLT (Bolt Biotherapeutics)|Multiplikator Forward P/S hcwbiologics.com (HCWB)|Rasio rega marang prakiraan pendapatan Aptevo Therapeutics Inc. APVO|AIM: Kapitalisasi marang prakiraan pendapatan|Aditxt Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep GRI Bio Inc|XRTX (XORTX) - Multiplikator forward rega marang pendapatan|HIND: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Revelation Biosciences|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep indaptusrx.com INDP|Multiplikator forward rega marang pendapatan SCNI (Scinai Immunotherapeutics Ltd.)|Multiplikator Forward P/S calcimedica.com (CALI)|Rasio rega marang prakiraan pendapatan Affimed N.V. AFMD|Rega forward marang dodolan ALLK|HOOK - Rasio rega marang prakiraan pendapatan|IGM Biosciences, Inc. (IGMS) - Multiplikator forward rega marang pendapatan|ITOS: Multiplikator Forward P/S|Ocean Biomedical Inc (OCEA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Rasio rega marang prakiraan pendapatan THRD
